210 related articles for article (PubMed ID: 11517301)
1. The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers.
Biswas DK; Dai SC; Cruz A; Weiser B; Graner E; Pardee AB
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10386-91. PubMed ID: 11517301
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells.
Biswas DK; Cruz AP; Gansberger E; Pardee AB
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8542-7. PubMed ID: 10900013
[TBL] [Abstract][Full Text] [Related]
3. [The nuclear factor kappa B activation: the key step of cell proliferation in estrogen receptor-negative breast cancer cells].
Wang HJ; Wu ZY; Fan P; Bian JM
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):1014-6. PubMed ID: 16194364
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation.
Biswas DK; Martin KJ; McAlister C; Cruz AP; Graner E; Dai SC; Pardee AB
Cancer Res; 2003 Jan; 63(2):290-5. PubMed ID: 12543776
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer.
Singh S; Shi Q; Bailey ST; Palczewski MJ; Pardee AB; Iglehart JD; Biswas DK
Mol Cancer Ther; 2007 Jul; 6(7):1973-82. PubMed ID: 17620428
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.
Nakshatri H; Bhat-Nakshatri P; Martin DA; Goulet RJ; Sledge GW
Mol Cell Biol; 1997 Jul; 17(7):3629-39. PubMed ID: 9199297
[TBL] [Abstract][Full Text] [Related]
8. B-cell receptor- and phorbol ester-induced NF-kappaB and c-Jun N-terminal kinase activation in B cells requires novel protein kinase C's.
Krappmann D; Patke A; Heissmeyer V; Scheidereit C
Mol Cell Biol; 2001 Oct; 21(19):6640-50. PubMed ID: 11533251
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha-induced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-gamma 2, protein kinase C-alpha, tyrosine kinase, NF-kappa B-inducing kinase, and I-kappa B kinase 1/2 pathway.
Chen CC; Sun YT; Chen JJ; Chiu KT
J Immunol; 2000 Sep; 165(5):2719-28. PubMed ID: 10946303
[TBL] [Abstract][Full Text] [Related]
10. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells.
Eddy SF; Guo S; Demicco EG; Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2005 Dec; 65(24):11375-83. PubMed ID: 16357145
[TBL] [Abstract][Full Text] [Related]
11. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Traish AM; Mercurio F; Sonenshein GE
Cancer Res; 2001 May; 61(9):3810-8. PubMed ID: 11325857
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
[TBL] [Abstract][Full Text] [Related]
13. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
[TBL] [Abstract][Full Text] [Related]
14. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE
Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626
[TBL] [Abstract][Full Text] [Related]
15. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis.
Takada Y; Singh S; Aggarwal BB
J Biol Chem; 2004 Apr; 279(15):15096-104. PubMed ID: 14711835
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of I-kappa B kinase alpha/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression.
Huang WC; Chen JJ; Inoue H; Chen CC
J Immunol; 2003 May; 170(9):4767-75. PubMed ID: 12707358
[TBL] [Abstract][Full Text] [Related]
17. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.
Xu C; Shen G; Chen C; Gélinas C; Kong AN
Oncogene; 2005 Jun; 24(28):4486-95. PubMed ID: 15856023
[TBL] [Abstract][Full Text] [Related]
18. Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells.
Bhat-Nakshatri P; Sweeney CJ; Nakshatri H
Oncogene; 2002 Mar; 21(13):2066-78. PubMed ID: 11960379
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis.
Shishodia S; Koul D; Aggarwal BB
J Immunol; 2004 Aug; 173(3):2011-22. PubMed ID: 15265936
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
